A critical role of protein damage response in mediating cancer drug resistance
This study identifies protein damage response (PDR) as a key mechanism in cancer drug resistance, showing that targeting PDR components can enhance drug efficacy in resistant cells.
bioRxiv · Jul 17, 2024 · PreprintCancer Biology